Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Protein engineering of a stable and potent anti-inflammatory IL-37-Fc fusion with enhanced therapeutic potential.
Cell Chem Biol. 2022 Apr 21;29(4):586-596.e4. doi: 10.1016/j.chembiol.2021.10.004. Epub 2021 Oct 25.
Cell Chem Biol. 2022.
PMID: 34699747
Free article.
Immunogenicity, Inflammation, and Lipid Accumulation in Cynomolgus Monkeys Infused with a Lipidated Tetranectin-ApoA-I Fusion Protein.
Regenass-Lechner F, Staack RF, Mary JL, Richter WF, Winter M, Jordan G, Justies N, Langenkamp A, Garrido R, Albassam M, Singer T, Atzpodien EA.
Regenass-Lechner F, et al.
Toxicol Sci. 2016 Apr;150(2):378-89. doi: 10.1093/toxsci/kfw004. Epub 2016 Jan 18.
Toxicol Sci. 2016.
PMID: 26781512
Item in Clipboard
Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B.
Wildum S, Korolowicz KE, Suresh M, Steiner G, Dai L, Li B, Yon C, De Vera Mudry MC, Regenass-Lechner F, Huang X, Hong X, Murreddu MG, Kallakury BV, Young JAT, Menne S.
Wildum S, et al. Among authors: regenass lechner f.
Front Immunol. 2022 May 23;13:884113. doi: 10.3389/fimmu.2022.884113. eCollection 2022.
Front Immunol. 2022.
PMID: 35677037
Free PMC article.
Item in Clipboard
Morphologic and functional effects of gamma secretase inhibition on splenic marginal zone B cells.
de Vera Mudry MC, Regenass-Lechner F, Ozmen L, Altmann B, Festag M, Singer T, Müller L, Jacobsen H, Flohr A.
de Vera Mudry MC, et al. Among authors: regenass lechner f.
Int J Alzheimers Dis. 2012;2012:289412. doi: 10.1155/2012/289412. Epub 2012 Dec 17.
Int J Alzheimers Dis. 2012.
PMID: 23316412
Free PMC article.
Item in Clipboard
Development of a nonhuman primate challenge model to evaluate CD8+ T cell responses to an adenovirus-based vaccine expressing SIV proteins upon repeat-dose treatment with checkpoint inhibitors.
Graveline R, Haida M, Dumont C, Poulin D, Poitout-Belissent F, Samadfam R, Kronenberg S, Regenass-Lechner F, Prell R, Piche MS.
Graveline R, et al. Among authors: regenass lechner f.
MAbs. 2022 Jan-Dec;14(1):1979447. doi: 10.1080/19420862.2021.1979447.
MAbs. 2022.
PMID: 34923919
Free PMC article.
Item in Clipboard
Current nonclinical approaches for immune assessments of immuno-oncology biotherapeutics.
Grimaldi C, Ibraghimov A, Kiessling A, Rattel B, Ji C, Fuller CL, Brennan FR, Regenass-Lechner F, Shenton J, Price KD, Piché MS, Steeves MA, Prell R, Dudal S, Kronenberg S, Freebern W, Blanset D.
Grimaldi C, et al. Among authors: regenass lechner f.
Drug Discov Today. 2023 Feb;28(2):103440. doi: 10.1016/j.drudis.2022.103440. Epub 2022 Nov 12.
Drug Discov Today. 2023.
PMID: 36375739
Free article.
Review.
Item in Clipboard
Cite
Cite